Total Payments
$475,019
2024 Payments
$21,693
Companies
61
Transactions
1,634
Medicare Patients
16,596
Medicare Billing
$811,612
Payment Breakdown by Category
Other$406,672 (85.6%)
Food & Beverage$28,191 (5.9%)
Consulting$21,950 (4.6%)
Travel$17,745 (3.7%)
Education$402.25 (0.1%)
Gifts$59.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $406,672 | 297 | 85.6% |
| Food and Beverage | $28,191 | 1,166 | 5.9% |
| Consulting Fee | $21,950 | 10 | 4.6% |
| Travel and Lodging | $17,745 | 137 | 3.7% |
| Education | $402.25 | 23 | 0.1% |
| Gift | $59.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $139,006 | 280 | $0 (2024) |
| Lilly USA, LLC | $81,564 | 266 | $0 (2024) |
| Novo Nordisk Inc | $77,431 | 209 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $57,140 | 118 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $51,089 | 113 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $38,949 | 96 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $16,850 | 48 | $0 (2024) |
| Amgen Inc. | $2,071 | 94 | $0 (2024) |
| Corcept Therapeutics | $1,951 | 32 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $1,550 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,693 | 157 | Novo Nordisk Inc ($10,985) |
| 2023 | $43,882 | 229 | Lilly USA, LLC ($21,371) |
| 2022 | $67,771 | 235 | Lilly USA, LLC ($24,983) |
| 2021 | $42,032 | 183 | Novo Nordisk Inc ($11,547) |
| 2020 | $45,641 | 160 | Novo Nordisk Inc ($17,583) |
| 2019 | $41,567 | 160 | SANOFI-AVENTIS U.S. LLC ($9,993) |
| 2018 | $78,378 | 206 | SANOFI-AVENTIS U.S. LLC ($40,162) |
| 2017 | $134,054 | 304 | SANOFI-AVENTIS U.S. LLC ($74,056) |
All Payment Transactions
1,634 individual payment records from CMS Open Payments — Page 1 of 66
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Bone Health | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 12/10/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 12/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes Care | ||||||
| 12/09/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/04/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Durable Pump | ||||||
| 12/03/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Rare Disease | ||||||
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $23.08 | General |
| 11/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 11/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: Bone Health | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $13.11 | General |
| 11/05/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Diabetes | ||||||
| 11/03/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Endocrinology | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,873 | 9,069 | $567,742 | $219,376 |
| 2022 | 24 | 3,754 | 7,443 | $506,455 | $172,654 |
| 2021 | 27 | 4,875 | 10,017 | $696,974 | $242,998 |
| 2020 | 25 | 4,094 | 8,170 | $583,050 | $176,584 |
Total Patients
16,596
Total Services
34,699
Medicare Billing
$811,612
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 39 | 3,360 | $92,232 | $62,532 | 67.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 300 | 462 | $170,478 | $61,668 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 221 | 270 | $73,980 | $22,241 | 30.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 186 | 257 | $28,270 | $7,427 | 26.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 283 | 434 | $26,909 | $7,130 | 26.5% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 214 | 285 | $9,960 | $7,090 | 71.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 324 | 524 | $26,200 | $6,809 | 26.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 365 | 596 | $23,244 | $6,131 | 26.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 64 | 65 | $19,435 | $5,870 | 30.2% |
| 83721 | Ldl cholesterol level | Office | 2023 | 324 | 525 | $18,375 | $5,355 | 29.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 379 | 640 | $7,040 | $5,326 | 75.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 105 | 172 | $15,824 | $4,560 | 28.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 278 | 468 | $16,848 | $4,417 | 26.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 39 | 39 | $3,120 | $2,957 | 94.8% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 205 | 318 | $10,494 | $2,806 | 26.7% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 28 | 34 | $5,202 | $1,375 | 26.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 41 | 41 | $2,132 | $1,290 | 60.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 101 | 134 | $3,886 | $1,020 | 26.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 143 | 163 | $3,423 | $912.22 | 26.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 146 | 167 | $3,173 | $839.06 | 26.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 39 | 56 | $3,640 | $629.64 | 17.3% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 21 | 27 | $1,701 | $438.90 | 25.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 14 | 18 | $1,224 | $288.32 | 23.6% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 14 | 14 | $952.00 | $264.88 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 374 | 515 | $141,110 | $44,525 | 31.6% |
About Dr. James Neifing, MD
Dr. James Neifing, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437207941.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Neifing, MD has received a total of $475,019 in payments from pharmaceutical and medical device companies, with $21,693 received in 2024. These payments were reported across 1,634 transactions from 61 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($406,672).
As a Medicare-enrolled provider, Neifing has provided services to 16,596 Medicare beneficiaries, totaling 34,699 services with total Medicare billing of $811,612. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Portland, OR
- Active Since 01/08/2007
- Last Updated 03/07/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1437207941
Products in Payments
- JARDIANCE (Drug) $81,285
- SOLIQUA (Drug) $68,924
- INVOKANA (Drug) $57,153
- TOUJEO (Drug) $39,949
- FARXIGA (Drug) $38,929
- MOUNJARO (Drug) $35,497
- Rybelsus (Drug) $30,713
- RYBELSUS (Drug) $20,556
- Ozempic (Drug) $19,063
- Kerendia (Drug) $16,850
- TOUJEO (Biological) $9,508
- SOTAGLIFLOZIN (Drug) $8,061
- SOLIQUA 100/33 (Drug) $6,939
- SOLIQUA 100/33 (Biological) $5,231
- LYUMJEV (Drug) $2,129
- Korlym (Drug) $1,951
- EYLEA (Biological) $1,550
- EVENITY (Biological) $964.01
- Repatha (Biological) $543.13
- Dexcom G6 Transmitter (Medical Supply) $519.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Portland
Mr. Michael Mcclung, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.6M
Endocrinology, Diabetes & Metabolism $1.6M
Maria Fleseriu, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $418,716
Endocrinology, Diabetes & Metabolism $418,716
Rodica Busui, Md, Phd, MD, PHD
Endocrinology, Diabetes & Metabolism — Payments: $211,479
Endocrinology, Diabetes & Metabolism $211,479
Jonathan Purnell, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $209,631
Endocrinology, Diabetes & Metabolism $209,631
Nancy Curosh, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $194,307
Endocrinology, Diabetes & Metabolism $194,307
Andrew Ahmann, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $109,693
Endocrinology, Diabetes & Metabolism $109,693